125 related articles for article (PubMed ID: 36137821)
1. Higher SUV
Wrenn SM; Moore AL; Shah HJ; Barletta JA; Vaidya A; Kilbridge KL; Doherty GM; Jacene HA; Nehs MA
Am J Surg; 2023 Feb; 225(2):309-314. PubMed ID: 36137821
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
3. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
[TBL] [Abstract][Full Text] [Related]
6. Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center.
Maciel J; Cavaco D; Fraga D; Donato S; Simões H; Sousa R; Simões-Pereira J
Hormones (Athens); 2023 Mar; 22(1):131-138. PubMed ID: 36477790
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
[TBL] [Abstract][Full Text] [Related]
9. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N
Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985
[TBL] [Abstract][Full Text] [Related]
10. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA
JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of pretreatment
Sung AJ; Weiss BD; Sharp SE; Zhang B; Trout AT
Pediatr Radiol; 2021 Jul; 51(8):1400-1405. PubMed ID: 33629142
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-DOTAGA-IAC PET/CT for Imaging Metastatic and Recurrent Adrenocortical Carcinoma: A Case Series.
Pandey S; Walia R; Kumar R; Chopra S; Rana N; Chatterjee D; Satz S; Mittal BR; Shukla J
Clin Nucl Med; 2023 Feb; 48(2):e95-e98. PubMed ID: 36607383
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of
Xian WJ; Feng YL; Wang Y; Yang M; Lu SN
Br J Radiol; 2022 Jan; 95(1129):20210279. PubMed ID: 34813375
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma.
Lee D; Yun T; Koo Y; Chae Y; Chang D; Yang MP; Kang BT; Kim H
BMC Vet Res; 2022 Jan; 18(1):15. PubMed ID: 34980137
[TBL] [Abstract][Full Text] [Related]
17. Clinical Effectiveness of Preoperative 18F-FDG PET/CT in Predicting Pathological Tumor Grade in Patients with Pseudomyxoma Peritonei Originating from Appendix: A Retrospective Cohort Study.
Aso K; Gohda Y; Hotta M; Minamimoto R; Shimizu Y; Uemura Y; Yano H
Ann Surg Oncol; 2024 Mar; 31(3):1990-1995. PubMed ID: 38082170
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value.
Tessonnier L; Ansquer C; Bournaud C; Sebag F; Mirallié E; Lifante JC; Palazzo FF; Morange I; Drui D; de la Foucardère C; Mancini J; Taïeb D
World J Surg; 2013 Jan; 37(1):107-12. PubMed ID: 23001287
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
Nunes ML; Rault A; Teynie J; Valli N; Guyot M; Gaye D; Belleannee G; Tabarin A
World J Surg; 2010 Jul; 34(7):1506-10. PubMed ID: 20396886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
